Oral Cannabidiol for Tobacco Cessation
Public ClinicalTrials.gov record NCT05445804. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Cannabidiol is a compound found in cannabis plants that is well tolerated, has low abuse liability, and might be an effective medication to promote tobacco cessation. This clinical study will use a validated approach for screening tobacco cessation medications to determine if oral cannabidiol increases short-term tobacco abstinence, and evaluate mechanisms that might explain how cannabidiol alters smoking behavior. Results from this study will provide data on the therapeutic potential of cannabidiol for tobacco cessation.
Study identification
- NCT ID
- NCT05445804
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 50 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2022
- Primary completion
- Nov 30, 2026
- Completion
- Jan 31, 2027
- Last update posted
- Jan 6, 2026
2022 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Johns Hopkins Behavioral Pharmacology Research Unit | Baltimore | Maryland | 21224 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Tobacco Dependence trials
Other public records listing Tobacco Dependence. Sorted by last update posted; newest first. Not a recommendation.
- NCT07220356: C-Raven, a Virtual Tobacco Cessation Intervention in Residency Clinics Active, not recruiting
- NCT05429892: FRESH Delivers: An Innovative Approach to Reducing Tobacco Use Among Rural Smokers Active, not recruiting
- NCT06966362: Varenicline for Smoking Reduction in Veterans Not Ready To Quit Not yet recruiting
- NCT04832659: Assessment of Biomarkers in Children to Help Parents Quit Tobacco Active, not recruiting
- NCT06218056: Cannabidiol for Reducing Cigarette Use Recruiting
- NCT03912194: Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05445804, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 6, 2026 · Synced Jul 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05445804 live on ClinicalTrials.gov.